在患有慢性鼻炎与鼻和严重喘的并发症患者中对抗IL-5治疗的反应:研究方案
Petros Bakakos1, Isam Alobid2, Jannis Constantinidis3
11st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, Greece.
The journal of allergy and clinical immunology. Global
|November 18, 2024
概括
梅波利祖马布可以改善患有严重喘和具有鼻息肉的慢性鼻炎的患者的生活质量. 这项研究评估了在这些并发症条件下其现实世界的有效性.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 严重的喘 (SA) 和带鼻息肉的慢性鼻炎 (CRSwNP) 经常同时存在,由eosinophilic炎症驱动.
- 这种并发症会对疾病严重程度和与健康相关的生活质量 (HRQoL) 产生负面影响.
- 抗IL-5疗法Mepolizumab在SA和CRSwNP中都显示出有效性,但需要真实世界的数据.
研究的目的:
- 为了评估mepolizumab对SA和CRSwNP患者的HRQoL的现实有效性.
- 评估这些患者群体的二次安全性和疗效结果.
- 为了研究梅波利祖马布对不同疾病严重程度的影响.
主要方法:
- 未来的,欧洲的,现实世界的队列研究 (RESPONSE).
- 两个成年患者队列:SA患有CRSwNP,CRSwNP患有喘.
- 多达350名患者接受了新的mepolizumab处方,并进行了12个月的随访.
主要成果:
- 主要终点:12个月后HRQoL的改善 (SNOT-22问卷).
- 二级终点:梅波利祖马布的安全性和有效性.
- 对伴随性疾病和较轻症形式的治疗效应的分析.
结论:
- 梅波利祖马布在改善SA和CRSwNP并发症的HRQoL方面表现出现实世界的有效性.
- 支持使用抗IL-5疗法来管理这些复杂的呼吸系统疾病.
- 提供了证据,以优化早期治疗与mepolizumab.
更多相关视频
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
222
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
222
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182